The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Orbimed Capital Gp Vi Llc since year 2005.
The trader's CIK number is 1682115.
At the time of this reporting, Orbimed Capital Gp Vi Llc is the of Alpine Immune Sciences, Inc. .
(stock ticker symbol ALPN).
See this page for all insider trading activities at Alpine Immune Sciences, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-01-18||ALPN||Alpine Immune Sciences, Inc.||Buy||372,439||5.37||1,999,997|
|2018-07-23||CNST||Constellation Pharmaceuticals Inc||Buy||200,000||15.00||3,000,000|
|2018-02-08||KALA||Kala Pharmaceuticals, Inc.||Buy||25,000||12.93||323,250|
|2018-02-02||KALA||Kala Pharmaceuticals, Inc.||Buy||37,840||14.73||557,383|
|2018-02-01||KALA||Kala Pharmaceuticals, Inc.||Buy||22,840||14.99||342,371|
|2018-01-31||KALA||Kala Pharmaceuticals, Inc.||Buy||339,400||15.00||5,091,000|
|2018-01-29||KALA||Kala Pharmaceuticals, Inc.||Buy||50,000||14.99||749,500|
|2018-01-26||KALA||Kala Pharmaceuticals, Inc.||Buy||22,760||14.93||339,806|
|2018-01-19||KALA||Kala Pharmaceuticals, Inc.||Buy||74,931||14.95||1,120,218|
|2018-01-22||KALA||Kala Pharmaceuticals, Inc.||Buy||75,000||14.98||1,123,500|
|2018-01-23||KALA||Kala Pharmaceuticals, Inc.||Buy||4,363||14.99||65,401|
|2018-01-12||KALA||Kala Pharmaceuticals, Inc.||Buy||38,354||14.50||556,133|
|2018-01-24||KALA||Kala Pharmaceuticals, Inc.||Buy||64,637||14.91||963,737|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Gp Vi Llc ( of Alpine Immune Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.